ErbB-3 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

ErbB-3 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
ErbB-3 shRNA Plasmid (h)

Product Specs
ItemErbB-3 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-35327-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Nameerb-b2 receptor tyrosine kinase 3
NCBI Gene AliasesErbB-3, FERLK, HER3, LCCS2, MDA-BF-1, VSCN1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancerBritish journal of cancerFebruary 1, 2019Li Z, Liao J, Yang Z, Choi EY, Lapidus RG, Liu X, Cullen KJ, Dan H.

(2) Algal photoprotection is regulated by the E3 ligase CUL4-DDB1^DET1Nature plantsJanuary 1, 2019Aihara Y, Fujimura-Kamada K, Yamasaki T, Minagawa J.

(3) Downregulation of ERBB3 decreases the proliferation, migration and invasion of cervical cancer cells though the interaction with MTK-1Oncology lettersSeptember 1, 2018Du J, Zhou S, Wang L, Yu M, Mei L.

(4) Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung CancerMolecular cancer therapeuticsSeptember 1, 2018Shin DH, Jo JY, Han JY.

(5) Transactivated Epidermal Growth Factor Receptor Recruitment of α-actinin-4 From F-actin Contributes to Invasion of Brain Microvascular Endothelial Cells by Meningitic Escherichia coliFrontiers in cellular and infection microbiologyJanuary 1, 2018Fu J, Li L, Yang X, Yang R, Amjad N, Liu L, Tan C, Chen H, Wang X.

(6) Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cellsTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineMay 1, 2016Kim J, Lee J, Kim C, Choi J, Kim A.

(7) YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progressionOncogeneDecember 10, 2015He C, Lv X, Hua G, Lele SM, Remmenga S, Dong J, Davis JS, Wang C.

(8) Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell linesOncology reportsSeptember 1, 2014Jeong H, Kim J, Lee Y, Seo JH, Hong SR, Kim A.

(9) HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285OncoscienceJanuary 1, 2014Takagi S, Banno H, Hayashi A, Tamura T, Ishikawa T, Ohta Y.

(10) HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cellsBMC cancerAugust 12, 2013Kim J, Jeong H, Lee Y, Kim C, Kim H, Kim A.

(11) Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutantsThe Journal of biological chemistryJune 7, 2013Fan YX, Wong L, Marino MP, Ou W, Shen Y, Wu WJ, Wong KK, Reiser J, Johnson GR.

(12) Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cellsMolecular cancer research : MCRDecember 1, 2012Wu Y, Ginther C, Kim J, Mosher N, Chung S, Slamon D, Vadgama JV.

(13) Regulation of cigarette smoke-induced mucin expression by neuregulin1β/ErbB3 signalling in human airway epithelial cellsBasic & clinical pharmacology & toxicologyJuly 1, 2011Yu H, Li Q, Kolosov VP, Perelman JM, Zhou X.

(14) Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cellsInternational journal of cancerMay 1, 2007Liu B, Ordonez-Ercan D, Fan Z, Edgerton SM, Yang X, Thor AD.

Be the First to Write a Review!